78
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Combination of valproate and paroxetine in mice exposed to picrotoxin

Pages 2583-2589 | Published online: 23 May 2012

References

  • TurkdoganDToplanSKarakocYLipid peroxidation and antioxidative enzyme activities in childhood epilepsyJ Child Neurol200217967367612503643
  • HamedSAAbdellahMMTrace elements and electrolytes homeostasis and their relation to antioxidant enzyme activity in brain hyperexcitability of epileptic patientsJ Pharmacol Sci200496434935915599105
  • HermannBPSeidenbergMBellBWoodardARuteckiPShethRComorbid psychiatric symptoms in temporal lobe epilepsy: association with chronicity of epilepsy and impact on quality of lifeEpilepsy Behav20001318419012609152
  • HardenCLThe co-morbidity of depression and epilepsy. Epidemiology, etiology, and treatmentNeurology200259S485512270969
  • AhernTHJavorsMAEaglesDAThe effect of chronic norepinephrine transporter inactivation on seizure susceptibility in miceNeuropsychopharmacol20052721319
  • BlierPDe MontignyCCurrent advances and trends in the treatment of depressionTrends Pharmacol Sci1994152202267940983
  • ArtigasFSelective serotonin/noradrenaline reuptake inhibitors (SNRIs)CNS Drugs19947989
  • VetulaniJNalepaIAntidepressants: past, present and futureEur J Pharmacol200040535136311033340
  • DelgadoPLPriceLHHeningerGRCharneyDSNeurochemistry of Affective DisordersHandbook of Affective DisordersPaytkelESLivingston, NYChurchill1992219253
  • DeakinBDursunSOptimizing antidepressant treatment: efficacy and tolerabilityInt Clin Psychopharmacol200217Suppl 1S132412369607
  • DikeosDGPapadimitriouGNGenetic investigation of dopamine and GABA in mood disordersAnn Gen Hosp Psychiatry20032S83
  • PrueterCNorraCMood disorders and their treatment in patients with epilepsyJ Neuropsychiatry Clin Neurosci2005171202815746479
  • BuckleyNAMcManusPRFatal toxicity of serotoninergic and other antidepressant drugs: analysis of United Kingdom mortality dataBr Med J20023251332133312468481
  • MontgomerySALoftHSanchezCEscitalopram (S-enantiomer of citalopram): clinical efficacy and onset of action predicted from a rat modelPharmacol Toxicol200188528228611393591
  • SiddiquiANazmiAKarimSKhanRPillaiKPalKEffect of Melatonin and Valproate In Epilepsy and DepressionInd J Pharmacol200133378381
  • DavidDBourinMJegoGPrzybylskiCJollietPGardierAEffects of acute treatment with paroxetine, citalopram and venlafaxine in vivo on noradrenaline and serotonin outflow: a microdialysis study in Swiss miceBr J Pharmacol200314061128113614530210
  • BenjaminJIwataRHazalettJKinetics of entry of proteins into the myelin membraneJ Neurochem19783110771085702136
  • GutteridgeJMQuinlanGJMalondialdhyde formation from lipid peroxides in the thiobarbituric acid test: the role of lipid radicals, iron salt and metal chelatorsJ Appl Biochem198354–52932996679543
  • GunawanSWaltonNTreimanDHigh performance liquid chromatography determination of selected amino acids in rat brain by precolumn derivatization with phenylisothiocyanateJ Chroma19905031177187
  • MontgomerySAAntidepressants and seizures: emphasis on newer agents and clinical implicationsInt J Clin Pract200559121435144016351676
  • RossettiVLombardADetermination of glutamate decarboxylase by high-performance liquid chromatographyJ Chromatogr B19966816367
  • BradfordMMA rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnal Biochem197672248254942051
  • DaileyJWNaritokuDKAntidepressants and seizure: clinical anecdotes overshadow neuroscienceBiochem Pharmacol199652132313298937441
  • TrimbleMNon-monoamine oxidase inhibitor antidepressants and epilepsy: a reviewEpilepsia197819241250354920
  • EdwardsJGAntidepressants and convulsionsLancet197921368136992708
  • SkowronDMStimelGLAntidepressants and the risk of seizuresPharmacotherapy19921218221549533
  • RosensteinDLNelsonJCJacobsSCSeizures associated with antidepressants: a reviewJ Clin Psychiatry1993542892998253696
  • KannerAMThe behavioral aspects of epilepsy: an overview of controversial issuesEpilepsy Behav20011101105
  • BrambillaPPerezJBaraleFSchettiniGSoaresJCGABAergic dysfunction in mood disordersMol Psychiatry20038872173712888801
  • ShinsukeWAkifumiINobumasaKTadafumiKPossible relationship between mitochondrial DNA polymorphisms and lithium response in bipolar disorderThe International Journal of Neuropsychopharmacology2003642142410.1017/S146114570300377814604458
  • PettyFKramerGLFultonMMoellerFGRushAJLow plasma GABA is a trait-like marker for bipolar illnessNeuropsychopharmacology1993921251328216695
  • SanacoraGMasonGFRothmanDLKrystalJHIncreased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitorsAm J Psychiatry2002159466366511925309
  • KuruvillaAUretskyNEffect of sodium valproate on motor function regulated by the activation of GABA receptorsPsychopharmacol198172167172
  • SunandaBSShankaranarayanaRRajuTRChronic restraint stress impairs acquisition and retention of spatial memory taskCurrent Science2000791115811584
  • GrilloCAPiroliGGRosellDRHoskinEKMcewenBSReaganLPRegion specific increases in oxidative stress and superoxide dismutase in the hippocampus of diabetic rats subjected to stressNeuroscience2003121113314012946706
  • SudhaKRaoAVRaoAOxidative stress and antioxidants in epilepsyClinica Chimiva Acta20013031924
  • ScharfmanHESollasALBergerREGoodmanJHElectrophysiological evidence of monosynaptic excitatory transmission between granule cells after seizure-induced mossy fiber sproutingJ Neurophysiol2003902536254714534276
  • AndersenBBMikkelsenMVesteragerADamMKristensenHBPedersenBNo influence of the antidepressant paroxetine on carbamazepine, valproate and phenytoinEpilepsy Res1991102–32012041840138
  • LauterbachEMendezMPsychopharmacological neuroprotection in neurodegenerative diseases, part III: criteria-based assessment: A report of the ANPA Committee on ResearchJ Neuropsychiatry Clin Neurosci200123324226021948886